, standard deviation (S.D.), and 95% credible intervals (CI) for the prostate cancer dataset were obtained using the proposed joint model, focusing on longitudinal PSA and ALP biomarkers and time-to-tumor shrinkage outcomes. The gene discussed is KLK3; the disease is neoplasm.